Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release.
Open Access
- 1 July 1990
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 86 (1) , 160-168
- https://doi.org/10.1172/jci114679
Abstract
Treatment of volunteers or animals with endotoxin in vivo results in reduced vascular reactivity to catecholamines. Endotoxin also causes liberation of the vasoactive cytokines interleukin-1 (IL-1) and tumor necrosis factor (TNF) from vascular smooth muscle and endothelial cells in culture. This study tested whether defects in contractility could be induced in isolated vascular tissue by prolonged exposure to endotoxin (1-100 ng/ml) in vitro, and whether IL-1 and TNF release by blood vessels is altered during the establishment of endotoxin induced contractile dysfunction. A concentration of endotoxin as low as 1 ng/ml suppressed contractions to norepinephrine (NE) and KCl; aortic sensitivity to NE also decreased. The presence of serum constituents or an intact endothelium were not necessary for endotoxin-induced vascular suppression. Aortas incubated with endotoxin liberated IL-1 and TNF in a dose-dependent fashion. The addition of dexamethasone or indomethacin during the incubations generally suppressed release of the cytokines and improved tissue reactivity to NE. The endotoxin-induced diminished vascular contraction and augmented IL-1 and TNF liberation required de novo protein synthesis; tissue incubated with endotoxin plus actinomycin D was completely shielded from the influence of endotoxin on vascular reactivity to NE. The association between endotoxin-induced vascular cytokine release and diminished contraction suggests a possible role for cytokines derived from the vasculature in the regulation of contractile function.This publication has 52 references indexed in Scilit:
- Interleukin 1 inhibits contraction of vascular smooth muscle.Journal of Clinical Investigation, 1989
- Corticosteroids suppress cyclooxygenase messenger RNA levels and prostanoid synthesis in cultured vascular cellsBiochemical and Biophysical Research Communications, 1988
- Interleukin 1 (IL-1) and tumour necrosis factor synergise in the induction of IL-1 synthesis by human vascular endothelial cellsImmunology Letters, 1988
- Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines.The Journal of Experimental Medicine, 1988
- ENDOTOXAEMIA: AN EARLY PREDICTOR OF SEPTICAEMIA IN FEBRILE PATIENTSThe Lancet, 1988
- Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells.The Journal of Experimental Medicine, 1987
- Inducible interleukin-1 gene expression in human vascular smooth muscle cells.Journal of Clinical Investigation, 1986
- Studies and Perspectives of Protein Kinase CScience, 1986
- Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.The Journal of Experimental Medicine, 1986
- The Role of Endotoxin during Typhoid Fever and Tularemia in Man. II. Altered Cardiovascular Responses to Catecholamines*Journal of Clinical Investigation, 1964